Abiopharma

MDU Resources Reports Second Quarter 2026 Results; Advances Infrastructure Growth Opportunities

Liberty Capital Reports Second Quarter 2026 Financial and Operating Results

Enhanced Group to Report Second Quarter 2026 Financial Results

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors

Gaia Commits to Two Seasons of New Original Series Beyond the Program with Jim Curtis

Live Ventures to Issue Fiscal Third Quarter 2026 Financial Results and Hold Earnings Conference Call on August 13, 2026

Cloudastructure Wins Full Guard Replacement Across Five-Building Southern California Office Portfolio for One of the Worlds Largest Commercial Real Estate Firms

Easy Environmental Solutions Is Saving 1000’s Of Trees From Disease & Forced Removal

Inuvo’s IntentKey a Powerful Tool in Identifying Net-New Open Enrollment Customers

Investors Title Company Announces Second Quarter 2026 Results

Neptune Flood Research Group Examines a Decade of Storms, Warns 2025s Quiet Hurricane Season Isnt a Trend

HCTIs Teyame Delivers a Full Year of Client Revenue in Six Months; €2 Million in Target

General Announcement: FINAL AWARDS IN RESPECT OF ARBITRATION BETWEEN RAFFLES K12 SDN BHD AND PEMBINAAN MITRAJAYA SDN BHD

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress